EN | VI

RegenoGel – Advanced Biotech Solution for Joint Health

RegenoGel is a cutting-edge biotechnology product developed through the integration of:

 

  • High-molecular-weight Hyaluronic Acid (HA): Enhances joint lubrication and supports joint function.

  • Fibrinogen: A key plasma protein involved in blood clotting and tissue repair.

These components are bound using Procore’s proprietary platform technology, resulting in a highly stable, animal-free bioproduct, ensuring optimal safety for patients.

Key Advantages of RegenoGel:

  • High efficacy: Rapid relief of joint pain and inflammation.
  • Long-lasting effects: A single injection can provide relief for at least 3 months—and up to 12 months depending on the individual.
  • Safe and minimally invasive: Suitable for various patient groups; contains no animal-derived substances.
  • Quick recovery: Patients can resume daily activities shortly after treatment.

Indications for RegenoGel:

  • Patients with osteoarthritis in the knee, hip, ankle, or shoulder joints.

  • Individuals with mild to moderate joint degeneration.

  • Patients who are not yet candidates for joint replacement surgery or wish to delay it.

Treatment Protocol:

  • A single intra-articular injection performed by a specialized physician.

  • Patients will be monitored and re-evaluated after 3 months. Based on clinical condition, follow-up injections may be considered every 6–12 months.

⚠️ Note: RegenoGel is a prescription-only medication and must be administered under the supervision of a rheumatologist or orthopedic specialist.

If you're looking for a safe, effective, and long-term solution for osteoarthritis, RegenoGel is a choice worth considering. Contact Goodie company today for a free consultation.